Atlas Trials

Compound Sodium Alginate Double Action Chewable Tablet Symptomatic Relief Study

Clinical trial NCT01869491 · COMPLETED

Trial details

NCT number
NCT01869491
Sponsor
Reckitt Benckiser Healthcare (UK) Limited
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Gastroesophageal Reflux DiseaseDyspepsia
Start date
2013-06-05
Primary completion
2014-05-01
Enrollment
1107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.